|
Volumn 12, Issue 12 SUPPL. 3, 2006, Pages
|
Model for End-Stage Liver Disease (MELD) exception for uncommon hepatic tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOSARCOMA;
ARTICLE;
BONE METASTASIS;
BONE SCINTISCANNING;
CARCINOID;
CAROLI DISEASE;
CHEMOTHERAPY;
CLINICAL OBSERVATION;
CYSTADENOCARCINOMA;
GLYCOGEN STORAGE DISEASE;
HEALTH CARE POLICY;
HEMANGIOENDOTHELIOMA;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LIVER ADENOMA;
LIVER FAILURE;
LIVER RESECTION;
LIVER SARCOMA;
LIVER TRANSPLANTATION;
LIVER TUMOR;
MALIGNANT TRANSFORMATION;
NEUROENDOCRINE TUMOR;
PATIENT SELECTION;
PRIORITY JOURNAL;
SURVIVAL RATE;
TUMOR RECURRENCE;
ADENOMA;
CARCINOID TUMOR;
HEMANGIOENDOTHELIOMA, EPITHELIOID;
HUMANS;
LIVER FAILURE;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
MODELS, BIOLOGICAL;
NEUROENDOCRINE TUMORS;
SEVERITY OF ILLNESS INDEX;
TISSUE AND ORGAN PROCUREMENT;
|
EID: 33845486106
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.20970 Document Type: Article |
Times cited : (5)
|
References (7)
|